ADAM DINIUS: Open Payments
NPI 1407634967 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,226 in 90 payments from 11 companies in 2025. Trend: 2023 $404 · 2024 $2,462 · 2025 $2,226
Food & beverage: $2,041Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $737 |
| ABBVIE INC. | 26 | $390 |
| GENZYME CORPORATION | 13 | $387 |
| UCB, Inc. | 4 | $177 |
| PFIZER INC. | 7 | $161 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Incyte Corporation | 2 | $55 |
| Lilly USA, LLC | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, CIBINQO, ILUMYA, RINVOQ, OPZELURA.
Industry payments across WA — which companies pay providers there.
